EU Agency Says Benefits of J&J Covid-19 Vaccine Outweigh Risks but Calls for Blood-Clot Warning
By Eric Sylvers
The European Union Medicines Agency said a warning should be
added to the product information of the Johnson & Johnson
Covid-19 vaccine that unusual blood clots with low blood platelets
is a very rare possible side effect. The agency said that the
overall benefits of the J&J shot outweigh the possible side
effects and that healthcare professionals should be on the lookout
for the combination of blood clots and low platelet levels.
(More to come)
Write to Eric Sylvers at email@example.com
(END) Dow Jones Newswires
April 20, 2021 10:56 ET (14:56 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.